MDT Medtronic plc. Ordinary Shares
$93,79
Kurs · Aug 19, 2026
Fundamentaldaten per Jun 18, 2026
52W-Spanne
$73–$106
62% of range
Analystenbewertung
BUY
34 analysts
Kursziel
$98
+5% upside
P/E (TTM)
25.1
ROE
9.8%
Nettogewinnmarge
13.2%
Über Medtronic plc. Ordinary Shares Unternehmensübersicht von Wikipedia
Medtronic plc mit Hauptsitz in Dublin ist ein börsennotiertes Unternehmen auf dem Gebiet der Medizintechnik. Das Unternehmen ist in den Aktienindizes S&P 100 und S&P 500 sowie dem Global Challenges Index vertreten.
Mehr lesen
Medtronic plc mit Hauptsitz in Dublin ist ein börsennotiertes Unternehmen auf dem Gebiet der Medizintechnik. Das Unternehmen ist in den Aktienindizes S&P 100 und S&P 500 sowie dem Global Challenges Index vertreten.
Bekannt ist die Firma für ihre Herzschrittmacher, implantierbare Kardioverter-Defibrillatoren, Herzklappen, Insulinpumpen, Aortenstentgrafts, Koronarstents und Neurostimulatoren. Von Medtronic werden mehr als die Hälfte aller weltweit implantierten Herzschrittmacher hergestellt.
Geschichte
Das Unternehmen wurde 1949 von Earl Bakken und Palmer Hermundslie gegründet. Momentan sind 91.000 Mitarbeiter bei Medtronic beschäftigt, die einen Umsatz von rund 29,7 Mrd. US-Dollar generieren.
Im Juni 2014 wurden Pläne bekannt, den irischen Konkurrenten Covidien zu kaufen. Die Übernahme wurde am 27. Januar 2015 abgeschlossen und der Sitz von Medtronic von Fridley, Minnesota nach Dublin verlegt.
Im August 2016 gab Medtronic die Übernahme von HeartWare International bekannt.
Deutschland
Die Medtronic GmbH in Deutschland hat seit 1970 ihren Sitz in Meerbusch. Ende 2008 wurde dort der neue Deutschlandsitz bezogen. Dort arbeiten etwa 240 der rund 800 deutschen Mitarbeiter.
Europa
Die Medtronic Österreich GmbH wurde am 12. April 1973 gegründet und hat ihren Sitz in Wien. Medtronics Hauptsitz für EMEA befindet sich in Tolochenaz (VD) in der Schweiz. In Europa sind über 6.000 Mitarbeiter tätig.
Image-, Produkt- und Sicherheitsprobleme
Implant files
Im November 2018 berichtete die Süddeutsche Zeitung im Zuge der Implant Files genannten internationalen Recherchen zu mangelhaften Implantaten: „Seit Jahren steht Medtronic im Ruf, in Interessenkonflikte, Steuertricks und Korruption verstrickt zu sein.“
ICD-Elektroden
Ende 2007 wurde bekannt, dass die Elektroden der Serie Sprint Fidelis unter Umständen brechen können und mit fünf Todesfällen in den USA in Zusammenhang gebracht werden, Medtronic zahlte im Jahr 2010 an 3.700 Kläger 268 Mio. US-Dollar.
IT-Sicherheitslücken
Anfang des Jahres 2017 informierten die Hacker Billy Rios und Jonathan Butts das Unternehmen über eine Schwachstelle in seinen Insulinpumpen. Rios und Butts programmierten u. a. eine Android-App, mit der sich indirekt die Insulindosierung mehrerer Pumpen aus verschiedenen Serien drahtlos manipulieren ließ. Erst Mitte 2019 reagierte Medtronic auf diese Informationen mittels eines Rückrufs. Außerdem wurden im August 2018 schwere Sicherheitslücken in der Software der Herzschrittmacher Adapta bekannt. Diese lassen sich mit geringem Aufwand dazu bewegen, manipulierte Firmware auszuführen oder den Betrieb ganz einzustellen. Auch hierauf wurde Medtronic von Rios und Butts bereits 18 Monate zuvor hingewiesen, zeigte sich aber unwillig, Abhilfe zu schaffen, weshalb Rios den Bug veröffentlichte. Im Oktober 2018 erhielt Medtronic dafür den österreichischen Negativpreis Big Brother Award in der Kategorie Business und Finanzen. Die US-amerikanische Cybersecurity and Infrastructure Security Agency (CISA) warnte in einem Beitrag Anfang des Jahres 2019 über zwei ähnliche Sicherheitslücken in vielen Defibrillator-Implantaten des Herstellers. Stand Januar 2020 sind diese Lücken für einige Modelle mittlerweile geschlossen, aber für andere weiterhin offen.
Vorwürfe zu Lücken im Datenschutz
Medtronic sieht sich einer Sammelklage gegenüber, die das Unternehmen und seine Tochtergesellschaft MiniMed beschuldigt, sensible Patientendaten ohne Zustimmung weitergegeben zu haben. Die Klage wurde im Namen eines Nutzers der InPen Diabetes Management App eingereicht, der im April 2023 erfuhr, dass seine persönlichen und geschützten Gesundheitsinformationen an Drittanbieter wie Google weitergeleitet wurden. Zu den weitergegebenen Daten gehören Namen, Telefonnummern, E-Mail-Adressen, IP-Adressen, Gerätekennungen und andere sensible medizinische Informationen.
Die Klage argumentiert, dass Medtronic und MiniMed bewusst entschieden haben, Tracking- und Authentifizierungstechnologien wie Google Analytics, Crashlytics und Firebase Authentication zu verwenden, um diese Daten zu sammeln und zu teilen. Diese Praktiken stehen im Widerspruch zu den Datenschutzrichtlinien und könnten gegen den Health Insurance Portability and Accountability Act (HIPAA) verstoßen, der den Schutz solcher Informationen sicherstellen soll.
Medtronic wies die Vorwürfe zurück und betonte, dass der Schutz von Patientendaten höchste Priorität habe und dass das Unternehmen robuste Prozesse und Technologien zum Schutz dieser Informationen einsetze.
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
MDT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$93.79
Marktkapitalisierung
$120.07B
P/E (TTM)
25.1
EPS (TTM)
$3.73
Umsatz (TTM)
$36.36B
Dividendenrendite
3.0%
ROE
9.8%
Verschuldungsgrad
—
52W-Spanne
$73 – $106
MDT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$36.36B
2017-04-28
→
2026-04-24
EPS
$3.73
2017-04-28
→
2026-04-24
Freier Cashflow
$5.43B
2017-04-28
→
2026-04-24
Margen
13.2%
2017-04-28
→
2018-04-27
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
MDT
Peer-Median
P/E (TTM)
25.1
26.5
P/S (TTM) (K/V (TTM))
3.3
2.9
P/B (K/B)
2.4
3.4
Price / FCF (Kurs / FCF)
22.1
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
MDT
Peer-Median
Operating Margin (Betriebsgewinnmarge)
17.8%
—
Net Profit Margin (Nettogewinnmarge)
13.2%
12.1%
ROA
5.2%
5.0%
ROE
9.8%
9.5%
ROIC
10.3%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
MDT
Peer-Median
Current Ratio (Liquiditätsgrad)
2.1
2.5
Quick Ratio
1.4
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
MDT
Peer-Median
Revenue YoY (Umsatz YoY)
8.4%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
5.2%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
3.8%
—
EPS YoY (EPS VjV)
3.3%
—
Net Income YoY (Nettogewinn YoY)
3.0%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
MDT
Peer-Median
Payout Ratio (Ausschüttungsquote)
75.8%
—
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite
3.0%
Ausschüttungsquote
75.8%
5J Div CAGR
—
| Ex-Datum | Betrag |
|---|---|
| 26. Juni 2026 | $0,7200 |
| 27. März 2026 | $0,7100 |
| 26. Dezember 2025 | $0,7100 |
| 26. September 2025 | $0,7100 |
| 27. Juni 2025 | $0,7100 |
| 28. März 2025 | $0,7000 |
| 27. Dezember 2024 | $0,7000 |
| 27. September 2024 | $0,7000 |
| 28. Juni 2024 | $0,7000 |
| 21. März 2024 | $0,6900 |
| 19. Dezember 2023 | $0,6900 |
| 21. September 2023 | $0,6900 |
| 22. Juni 2023 | $0,6900 |
| 23. März 2023 | $0,6800 |
| 20. Dezember 2022 | $0,6800 |
| 22. September 2022 | $0,6800 |
| 23. Juni 2022 | $0,6800 |
| 24. März 2022 | $0,6300 |
| 21. Dezember 2021 | $0,6300 |
| 23. September 2021 | $0,6300 |
MDT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
34 Analysten
- Starker Kauf 10 29,4%
- Kauf 12 35,3%
- Halten 12 35,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
25 Analysten · 2026-08-15
Median
$100.00
Jetzt
$93.79
Tief
$78.00
Hoch
$121.00
Median-Ziel
$100.00
+6,6%
Mittelwert-Ziel
$98.44
+5,0%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.02%
Nächster Bericht
Sep 01, 2026
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. Dezember 2026 | $1.55 | $1.56 | — |
| 30. Juni 2026 | $1.55 | $1.56 | -0.01% |
| 31. März 2026 | $1.36 | $1.35 | 0.01% |
| 31. Dezember 2025 | $1.36 | $1.33 | 0.03% |
| 30. September 2025 | $1.26 | $1.24 | 0.02% |
| 30. Juni 2025 | $1.62 | $1.59 | 0.03% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| MDT | $106.66B | 22.3 | 8.4% | 13.2% | 9.8% | — |
| STE | $21.63B | 27.9 | 8.7% | 13.2% | 11.3% | 44.2% |
| TRIB | — | — | — | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36.36B | $33.54B | $32.36B | $31.23B | $31.69B | $30.12B | $28.91B | $30.56B | $29.95B | $29.71B | $28.83B | $20.26B | |
| Cost of Revenue | $12.72B | $11.63B | $11.22B | $10.72B | $10.14B | $10.48B | $9.42B | $9.15B | $9.07B | $9.29B | $9.14B | $6.31B | |
| Gross Profit | · | · | · | · | · | · | · | · | $20.90B | $20.42B | $19.69B | $13.95B | |
| SG&A Expense | $11.78B | $10.85B | $10.74B | $10.41B | $10.29B | $10.15B | $10.11B | $10.42B | $10.24B | $10.02B | $9.47B | $6.90B | |
| Operating Income | $6.47B | $5.96B | $5.14B | $5.49B | $5.75B | $4.48B | $4.79B | $6.27B | $6.64B | $5.38B | $5.36B | $3.77B | |
| Interest Expense | · | · | $719M | $636M | $553M | $925M | $1.09B | $1.44B | $1.15B | $1.09B | $1.39B | $666M | |
| Other Non-op | $384M | $402M | $412M | $515M | $318M | $336M | $356M | $373M | $181M | $313M | $-107M | $-118M | |
| Pretax Income | $6.14B | $5.63B | $4.84B | $5.36B | $5.52B | $3.90B | $4.05B | $5.20B | $5.67B | $4.60B | $4.34B | $3.49B | |
| Income Tax | $1.30B | $936M | $1.13B | $1.58B | $456M | $265M | $-751M | $547M | $2.58B | $578M | $798M | $811M | |
| Net Income | $4.80B | $4.66B | $3.68B | $3.76B | $5.04B | $3.61B | $4.79B | $4.63B | $3.10B | $4.03B | $3.54B | $2.67B | |
| EPS (Basic) | $3.75 | $3.63 | $2.77 | $2.83 | $3.75 | $2.68 | $3.57 | $3.44 | $2.29 | $2.92 | $2.51 | $2.44 | |
| EPS (Diluted) | $3.73 | $3.61 | $2.76 | $2.82 | $3.73 | $2.66 | $3.54 | $3.41 | $2.27 | $2.89 | $2.48 | $2.41 | |
| Shares (Basic) | 1,281,800,000 | 1,285,600,000 | 1,327,700,000 | 1,329,800,000 | 1,342,400,000 | 1,344,900,000 | 1,340,700,000 | 1,346,400,000 | 1,356,700,000 | 1,378,900,000 | 1,409,600,000 | 1,095,500,000 | |
| Shares (Diluted) | 1,288,100,000 | 1,289,900,000 | 1,330,200,000 | 1,332,800,000 | 1,351,400,000 | 1,354,000,000 | 1,351,100,000 | 1,357,500,000 | 1,368,200,000 | 1,391,400,000 | 1,425,900,000 | 1,109,000,000 | |
| EBITDA | $9.43B | $8.82B | $7.79B | $8.18B | $8.46B | $7.19B | $7.45B | $8.93B | $9.29B | $8.25B | $8.11B | $5.07B |
Bilanz 30
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.95B | $2.22B | $1.28B | $1.54B | $3.71B | $3.59B | $4.14B | $4.39B | $3.67B | $4.97B | $2.88B | $4.84B | |
| Short-term Investments | $7.27B | $6.75B | $6.72B | $6.42B | $6.86B | $7.22B | $6.81B | $5.46B | $7.56B | $8.74B | $9.76B | $14.64B | |
| Receivables | $6.64B | $6.51B | $6.13B | $6.00B | $5.55B | $5.46B | $4.64B | $6.22B | $5.99B | $5.59B | $5.56B | $5.11B | |
| Inventory | $5.95B | $5.48B | $5.22B | $5.29B | $4.62B | $4.31B | $4.23B | $3.75B | $3.58B | $3.34B | $3.47B | $3.46B | |
| Prepaid Expense | · | · | · | · | · | · | · | · | · | $1.86B | $1.93B | $1.45B | |
| Other Current Assets | $2.97B | $2.86B | $2.58B | $2.42B | $2.32B | $1.96B | $2.21B | $2.14B | $2.19B | $1.86B | $1.93B | · | |
| Current Assets | $24.79B | $23.81B | $21.93B | $21.68B | $23.06B | $22.55B | $22.03B | $21.97B | $22.98B | $24.87B | $23.60B | $30.84B | |
| PP&E (Net) | $7.42B | $6.84B | $6.13B | $5.57B | $5.41B | $5.22B | $4.83B | $4.67B | $4.60B | $4.36B | $4.84B | $4.70B | |
| PP&E (Gross) | · | · | · | · | $13.37B | $12.70B | $11.64B | $10.92B | $10.26B | $9.69B | $9.71B | $8.86B | |
| Accum. Depreciation | · | · | · | · | $7.95B | $7.48B | $6.82B | $6.25B | $5.66B | $5.33B | $4.87B | $4.16B | |
| Goodwill | $42.59B | $41.74B | $40.99B | $41.42B | $40.50B | $41.96B | $39.84B | $39.96B | $39.54B | $38.52B | $41.50B | $40.53B | |
| Intangibles | $10.15B | $11.67B | $13.22B | $14.84B | $15.60B | $17.74B | $19.06B | $20.56B | $21.72B | $23.41B | $26.90B | $28.10B | |
| Other Non-current Assets | $4.15B | $3.58B | $4.05B | $3.96B | $3.01B | $2.44B | $2.09B | $1.01B | $1.08B | $1.23B | $1.42B | $1.74B | |
| Total Assets | $93.03B | $91.68B | $89.98B | $90.95B | $90.98B | $93.08B | $90.69B | $89.69B | $91.39B | $99.86B | $99.64B | $106.69B | |
| Accounts Payable | $2.64B | $2.45B | $2.41B | $2.66B | $2.28B | $2.11B | $2.00B | $1.95B | $1.63B | $1.55B | $1.71B | $1.61B | |
| Short-term Debt | · | $0 | $1.07B | $0 | · | · | · | · | · | · | · | · | |
| Current Liabilities | $11.66B | $12.88B | $10.79B | $9.05B | $12.39B | $8.51B | $10.37B | $8.47B | $10.08B | $14.26B | $7.17B | $9.17B | |
| Capital Leases | $989M | $918M | $840M | $869M | $703M | $829M | $774M | $10M | · | · | · | · | |
| Deferred Tax | $362M | $403M | $515M | $708M | $884M | $1.03B | $1.17B | $1.28B | $1.42B | $2.98B | $3.73B | $4.70B | |
| Other Non-current Liabilities | $2.06B | $1.77B | $1.36B | $1.73B | $1.41B | $1.76B | $1.66B | $757M | $889M | $1.51B | $1.92B | $1.82B | |
| Total Liabilities | $42.96B | $43.42B | $39.56B | $39.28B | $38.26B | $41.48B | $39.82B | $39.48B | $40.57B | $49.53B | $47.58B | $53.45B | |
| Long-term Debt | · | · | · | · | · | · | $24.92B | $25.39B | $25.75B | $33.37B | $30.94B | $35.59B | |
| Total Debt | · | $0 | $1.07B | · | · | · | $24.92B | $25.39B | $25.75B | $33.37B | $30.94B | $35.59B | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $20.93B | $20.83B | $23.13B | $24.59B | $24.57B | $26.32B | $26.16B | $26.53B | $28.13B | $29.55B | $32.23B | · | |
| Retained Earnings | $32.64B | $31.48B | $30.40B | $30.39B | $30.25B | $28.59B | $28.13B | $26.27B | $24.38B | $23.27B | $21.70B | $54.41B | |
| AOCI | $-4.10B | $-4.28B | $-3.32B | $-3.50B | $-2.27B | $-3.48B | $-3.56B | $-2.71B | $-1.79B | $-2.61B | $-1.87B | $-1.18B | |
| Stockholders' Equity | $49.46B | $48.02B | $50.21B | $51.48B | $52.55B | $51.43B | $50.74B | $50.09B | $50.72B | $50.21B | $52.06B | $53.23B | |
| Liabilities + Equity | $93.03B | $91.68B | $89.98B | $90.95B | $90.98B | $93.08B | $90.69B | $89.69B | $91.39B | $99.86B | $99.64B | $106.69B | |
| Shares Outstanding | 1,280,177,293 | 1,281,934,628 | 1,311,000,000 | 1,331,000,000 | 1,331,000,000 | 1,345,000,000 | 1,341,000,000 | 1,341,000,000 | 1,354,000,000 | 1,369,000,000 | 1,399,000,000 | 1,422,000,000 |
Cashflow 20
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.96B | $2.86B | $2.65B | $2.70B | $2.71B | $2.70B | $2.66B | $2.66B | $2.64B | $2.92B | $2.82B | $1.31B | |
| Stock-based Comp | $457M | $429M | $393M | $355M | $359M | $344M | $297M | $290M | $344M | $348M | $375M | $439M | |
| Deferred Tax | $31M | $-339M | $-528M | $-253M | $-611M | $-461M | $-1.28B | $-438M | $-1.11B | $-876M | $-477M | $-819M | |
| Amort. of Intangibles | $1.77B | $1.81B | $1.69B | $1.70B | $1.73B | $1.78B | $1.76B | $1.76B | $1.82B | $1.98B | $1.90B | $733M | |
| Restructuring | · | · | $389M | $647M | $335M | $539M | $462M | · | · | · | · | · | |
| Other Non-cash | $-917M | $-569M | $599M | $-518M | $-148M | $49M | $762M | $-135M | $-293M | $463M | $-1.04B | $1.30B | |
| Operating Cash Flow | $7.33B | $7.04B | $6.79B | $6.04B | $7.35B | $6.24B | $7.23B | $7.01B | $4.68B | $6.88B | $5.22B | $4.90B | |
| CapEx | $1.90B | $1.86B | $1.59B | $1.46B | $1.37B | $1.35B | $1.21B | $1.13B | $1.07B | $1.25B | $1.05B | $571M | |
| Investing Cash Flow | $-2.93B | $-1.94B | $-2.37B | $-3.49B | $-1.66B | $-2.87B | $-3.20B | $-774M | $5.86B | $-1.57B | $2.25B | $-17.06B | |
| Debt Issued | $1.75B | $3.21B | $0 | $5.41B | $0 | $7.17B | $5.57B | $7.79B | $21M | $2.14B | $0 | $19.94B | |
| Net Debt Issued | $-1.18B | $3.21B | $0 | $-603M | $-1M | $-195M | $-542M | $-154M | $-7.35B | $1.28B | $-5.13B | $18.67B | |
| Stock Issued | $516M | $508M | $284M | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $1.03B | $3.23B | $2.14B | $645M | $2.54B | $652M | $1.33B | $2.88B | $2.17B | $3.54B | $2.83B | $1.92B | |
| Net Stock Activity | $-519M | $-3.23B | $-2.14B | $-645M | $-2.54B | $-652M | $-1.33B | $-2.88B | $-2.17B | $-3.54B | $-2.83B | $-1.92B | |
| Dividends Paid | $3.64B | $3.59B | $3.67B | $3.62B | $3.38B | $3.12B | $2.89B | $2.69B | $2.49B | $2.38B | $2.14B | $1.34B | |
| Financing Cash Flow | $-4.75B | $-4.36B | $-4.45B | $-4.96B | $-5.34B | $-4.14B | $-4.20B | $-5.43B | $-11.95B | $-3.28B | $-9.54B | $15.95B | |
| Net Change in Cash | $-269M | $934M | $-259M | $-2.17B | $121M | $-547M | $-253M | $724M | $-1.30B | $2.09B | $-1.97B | $3.44B | |
| Taxes Paid | $1.94B | $1.82B | $1.62B | $1.55B | $996M | $1.25B | $878M | $1.56B | $2.54B | $1.03B | $1.38B | $632M | |
| Free Cash Flow | $5.43B | $5.18B | $5.20B | $4.58B | $5.98B | $4.88B | $6.02B | $5.87B | $3.62B | $5.63B | $4.17B | $4.33B | |
| Levered FCF | · | · | $4.65B | $4.13B | $5.47B | $4.02B | $4.73B | $4.58B | $2.99B | $4.67B | $3.04B | $3.82B |
Rentabilität 8
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 69.8% | 68.7% | 68.3% | 68.9% | |
| Operating Margin | 17.8% | 17.8% | 15.9% | 17.6% | 18.1% | 14.9% | 16.6% | 20.5% | 22.2% | 17.9% | 18.4% | 18.6% | |
| Net Margin | 13.2% | 13.9% | 11.4% | 12.0% | 15.9% | 12.0% | 16.6% | 15.2% | 10.4% | 13.6% | 12.3% | 13.2% | |
| Pretax Margin | 16.9% | 16.8% | 14.9% | 17.2% | 17.4% | 12.9% | 14.0% | 17.0% | 18.9% | 15.5% | 15.0% | 17.2% | |
| EBITDA Margin | 25.9% | 26.3% | 24.1% | 26.2% | 26.7% | 23.9% | 25.8% | 29.2% | 31.0% | 27.8% | 28.1% | 25.0% | |
| ROA | 5.2% | 5.1% | 4.1% | 4.1% | 5.5% | 3.9% | 5.3% | 5.1% | 3.2% | 4.0% | 3.4% | 3.7% | |
| ROE | 9.8% | 9.5% | 7.2% | 7.2% | 9.7% | 7.1% | 9.5% | 9.2% | 6.2% | 7.9% | 6.7% | 7.4% | |
| ROIC | 10.3% | 10.3% | 7.7% | 7.5% | 10.0% | 8.1% | 7.5% | 7.4% | 4.7% | 5.6% | 5.2% | 3.2% |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.8 | 2.0 | 2.4 | 1.9 | 2.6 | 2.1 | 2.6 | 2.3 | 1.7 | 3.3 | 3.4 | |
| Quick Ratio | 1.4 | 1.2 | 1.3 | 1.5 | 1.3 | 1.9 | 1.5 | 1.9 | 1.7 | 1.4 | 2.5 | 2.7 | |
| Debt / Equity | · | 0.0 | 0.0 | · | · | · | 0.5 | 0.5 | 0.5 | 0.7 | 0.6 | 0.7 | |
| LT Debt / Equity | · | · | · | · | · | · | 0.4 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | |
| Interest Coverage | · | · | 7.2 | 8.6 | 10.4 | 4.8 | 4.4 | 4.3 | 5.8 | 4.9 | 3.8 | 5.7 |
Effizienz 3
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Inventory Turnover | 2.2 | 2.2 | 2.1 | 2.2 | 2.3 | 2.5 | 2.4 | 2.5 | 2.6 | 2.7 | 2.6 | 2.4 | |
| Receivables Turnover | 5.5 | 5.3 | 5.3 | 5.4 | 5.8 | 6.0 | 5.3 | 5.0 | 5.2 | 5.3 | 5.4 | 4.5 |
Wachstumsraten 10
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 8.4% | 3.6% | 3.6% | -1.5% | 5.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.2% | 1.9% | 2.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 3.3% | 30.8% | -2.1% | -24.4% | 40.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 9.8% | -1.1% | 1.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 7.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3.0% | 26.8% | -2.2% | -25.4% | 39.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 8.5% | -2.6% | 0.64% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 3.1% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 16
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $36.36B | $33.54B | $32.36B | $31.23B | $31.69B | $30.12B | $28.91B | $30.56B | $29.95B | $29.71B | $28.83B | $20.26B | |
| Net Income TTM | $4.80B | $4.66B | $3.68B | $3.76B | $5.04B | $3.61B | $4.79B | $4.63B | $3.10B | $4.03B | $3.54B | $2.67B | |
| Market Cap | $106.66B | $107.89B | $104.57B | $121.04B | $138.88B | $176.14B | $133.17B | $117.11B | $110.08B | $113.79B | $110.73B | $110.33B | |
| Enterprise Value | · | $98.92B | $97.63B | · | · | · | $147.14B | $132.65B | $124.61B | $133.45B | $129.04B | $126.44B | |
| P/E | 22.3 | 23.3 | 28.9 | 32.3 | 28.0 | 49.2 | 28.1 | 25.6 | 35.8 | 28.8 | 31.9 | 32.2 | |
| P/S | 2.9 | 3.2 | 3.2 | 3.9 | 4.4 | 5.8 | 4.6 | 3.8 | 3.7 | 3.8 | 3.8 | 5.4 | |
| P/B | 2.2 | 2.2 | 2.1 | 2.4 | 2.6 | 3.4 | 2.6 | 2.3 | 2.2 | 2.3 | 2.1 | 2.1 | |
| P / Cash Flow | 14.6 | 15.3 | 15.4 | 20.0 | 18.9 | 28.2 | 18.4 | 16.7 | 23.5 | 16.5 | 21.2 | 22.5 | |
| P / FCF | 19.7 | 20.8 | 20.1 | 26.4 | 23.2 | 36.1 | 22.1 | 19.9 | 30.4 | 20.2 | 26.5 | 25.5 | |
| EV / EBITDA | · | 11.2 | 12.5 | · | · | · | 19.7 | 14.9 | 13.4 | 16.2 | 15.9 | 24.9 | |
| EV / FCF | · | 19.1 | 18.8 | · | · | · | 24.4 | 22.6 | 34.5 | 23.7 | 30.9 | 29.2 | |
| EV / Revenue | · | 2.9 | 3.0 | · | · | · | 5.1 | 4.3 | 4.2 | 4.5 | 4.5 | 6.2 | |
| Dividend Yield | 3.4% | 3.3% | 3.5% | 3.0% | 2.4% | 1.8% | 2.2% | 2.3% | 2.3% | 2.1% | 1.9% | 1.2% | |
| Earnings Yield | 4.5% | 4.3% | 3.5% | 3.1% | 3.6% | 2.0% | 3.6% | 3.9% | 2.8% | 3.5% | 3.1% | 3.1% | |
| Payout Ratio | 75.8% | 77.0% | 99.7% | 96.2% | 67.1% | 86.5% | 60.4% | 58.1% | 80.3% | 59.0% | 60.5% | 50.0% | |
| Annual Payout | $3.64B | $3.59B | $3.67B | $3.62B | $3.38B | $3.12B | $2.89B | $2.69B | $2.49B | $2.38B | $2.14B | $1.34B |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.81B | $9.02B | $8.96B | $8.58B | $8.93B | $8.29B | $8.40B | $7.92B | $8.59B | $8.09B | $7.98B | $7.70B | $8.54B | $7.73B | $7.58B | $7.37B | |
| Cost of Revenue | $3.40B | $3.26B | $3.06B | $3.00B | $3.15B | $2.78B | $2.95B | $2.76B | $3.04B | $2.78B | $2.76B | $2.63B | $2.98B | $2.69B | $2.54B | $2.52B | |
| SG&A Expense | $3.06B | $2.96B | $2.96B | $2.81B | $2.72B | $2.72B | $2.76B | $2.65B | $2.76B | $2.67B | $2.69B | $2.61B | $2.62B | $2.62B | $2.62B | $2.57B | |
| Operating Income | $1.87B | $1.46B | $1.69B | $1.45B | $1.44B | $1.65B | $1.59B | $1.28B | $1.05B | $1.48B | $1.34B | $1.27B | $1.56B | $1.39B | $1.40B | $1.12B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $188M | $180M | $148M | · | $167M | $118M | $164M | |
| Interest Income | · | · | · | · | · | · | · | · | · | $170M | $148M | $111M | · | $118M | $73M | $55M | |
| Other Non-op | $138M | $121M | $92M | $33M | $0 | $72M | $173M | $157M | $5M | $177M | $154M | $76M | $174M | $149M | $109M | $83M | |
| Pretax Income | $1.83B | $1.40B | $1.60B | $1.30B | $1.26B | $1.54B | $1.56B | $1.27B | $856M | $1.47B | $1.31B | $1.20B | $1.55B | $1.38B | $1.40B | $1.04B | |
| Income Tax | $575M | $254M | $215M | $255M | $198M | $237M | $281M | $220M | $196M | $135M | $402M | $400M | $363M | $146M | $959M | $112M | |
| Net Income | $1.24B | $1.14B | $1.37B | $1.04B | $1.06B | $1.29B | $1.27B | $1.04B | $654M | $1.32B | $909M | $791M | $1.18B | $1.22B | $427M | $929M | |
| EPS (Basic) | $0.98 | $0.89 | $1.07 | $0.81 | $0.82 | $1.01 | $0.99 | $0.81 | $0.51 | $0.99 | $0.68 | $0.59 | $0.89 | $0.92 | $0.32 | $0.70 | |
| EPS (Diluted) | $0.96 | $0.89 | $1.07 | $0.81 | $0.81 | $1.01 | $0.99 | $0.80 | $0.50 | $0.99 | $0.68 | $0.59 | $0.88 | $0.92 | $0.32 | $0.70 | |
| Shares (Basic) | -2,564,400,000 | 1,282,600,000 | 1,282,000,000 | 1,281,600,000 | -2,572,500,000 | 1,282,400,000 | 1,282,400,000 | 1,293,300,000 | -2,662,700,000 | 1,329,700,000 | 1,330,200,000 | 1,330,500,000 | -2,659,200,000 | 1,330,200,000 | 1,329,400,000 | 1,329,400,000 | |
| Shares (Diluted) | -2,576,500,000 | 1,289,500,000 | 1,288,000,000 | 1,287,100,000 | -2,579,700,000 | 1,286,200,000 | 1,286,900,000 | 1,296,500,000 | -2,667,200,000 | 1,331,700,000 | 1,331,900,000 | 1,333,800,000 | -2,665,700,000 | 1,332,000,000 | 1,332,000,000 | 1,334,500,000 | |
| EBITDA | · | $1.46B | $1.69B | $2.19B | · | $1.65B | $1.59B | $1.94B | · | $1.48B | $1.34B | $1.94B | · | $1.39B | $1.40B | $1.79B |
Bilanz 27
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.95B | $1.15B | $1.28B | $1.27B | $2.22B | $1.24B | $1.39B | $1.31B | $1.28B | $1.62B | $1.31B | $1.34B | · | $4.52B | $4.83B | $2.14B | |
| Short-term Investments | $7.27B | $7.24B | $7.04B | $6.85B | $6.75B | $6.68B | $6.59B | $6.53B | $6.72B | $6.70B | $6.42B | $6.54B | · | $6.62B | $6.60B | $6.73B | |
| Receivables | $6.64B | $6.36B | $6.39B | $6.26B | $6.51B | $6.12B | $6.26B | $6.01B | $6.13B | $5.97B | $5.93B | $5.81B | · | $5.89B | $5.63B | $5.31B | |
| Inventory | $5.95B | $6.31B | $6.16B | $5.89B | $5.48B | $5.61B | $5.48B | $5.41B | $5.22B | $5.73B | $5.75B | $5.67B | · | $5.38B | $5.05B | $4.81B | |
| Other Current Assets | $2.97B | $3.02B | $3.12B | $2.95B | $2.86B | $2.87B | $2.71B | $2.68B | $2.58B | $2.50B | $2.66B | $2.52B | · | $2.96B | $3.29B | $3.15B | |
| Current Assets | $24.79B | $24.07B | $24.00B | $23.22B | $23.81B | $22.51B | $22.44B | $21.95B | $21.93B | $22.51B | $22.08B | $21.87B | · | $25.36B | $25.40B | $22.14B | |
| PP&E (Net) | $7.42B | $7.18B | $7.16B | $7.01B | $6.84B | $6.59B | $6.44B | $6.28B | $6.13B | $5.84B | $5.74B | $5.67B | · | $5.44B | $5.30B | $5.28B | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $13.93B | $13.50B | $13.32B | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $8.49B | $8.20B | $8.04B | |
| Goodwill | $42.59B | $41.89B | $41.81B | $42.01B | $41.74B | $40.82B | $41.16B | $41.08B | $40.99B | $41.16B | $40.82B | $41.44B | $41.42B | $41.56B | $40.42B | $40.32B | |
| Intangibles | $10.15B | $10.34B | $10.77B | $11.22B | $11.67B | $12.18B | $12.42B | $12.82B | $13.22B | $13.69B | $14.06B | $14.43B | · | $15.27B | $15.65B | $15.78B | |
| Other Non-current Assets | $4.15B | $4.04B | $3.75B | $3.58B | $3.58B | $4.25B | $4.01B | $4.06B | $4.05B | $4.04B | $3.96B | $3.91B | · | $3.14B | $3.12B | $3.09B | |
| Total Assets | $93.03B | $91.48B | $91.35B | $90.97B | $91.68B | $89.97B | $90.04B | $89.75B | $89.98B | $90.84B | $90.09B | $90.78B | · | $94.13B | $93.24B | $89.91B | |
| Accounts Payable | $2.64B | $2.57B | $2.58B | $2.56B | $2.45B | $2.29B | $2.38B | $2.29B | $2.41B | $1.99B | $2.17B | $2.24B | · | $2.21B | $2.20B | $2.18B | |
| Short-term Debt | · | · | · | · | $0 | · | · | · | $1.07B | · | · | · | · | · | · | · | |
| Current Liabilities | $11.66B | $9.49B | $9.94B | $11.53B | $12.88B | $11.84B | $12.20B | $10.29B | $10.79B | $9.79B | $9.66B | $9.05B | · | $14.42B | $14.46B | $14.05B | |
| Capital Leases | $989M | · | · | · | $918M | · | · | · | $840M | · | · | · | · | · | · | · | |
| Deferred Tax | $362M | $365M | $386M | $416M | $403M | $452M | $473M | $496M | $515M | $615M | $686M | $687M | · | $747M | $871M | $899M | |
| Other Non-current Liabilities | $2.06B | $1.77B | $1.76B | $1.81B | $1.77B | $1.53B | $1.53B | $1.47B | $1.36B | $1.41B | $1.56B | $1.72B | · | $1.73B | $1.44B | $1.44B | |
| Total Liabilities | $42.96B | $42.29B | $42.49B | $42.84B | $43.42B | $40.36B | $41.33B | $41.59B | $39.56B | $38.84B | $38.44B | $39.41B | · | $42.52B | $41.18B | $37.07B | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | |
| Paid-in Capital | $20.93B | $21.01B | $20.86B | $20.89B | $20.83B | $20.91B | $20.82B | $20.81B | $23.13B | $24.59B | $24.58B | $24.59B | · | $24.51B | $24.44B | $24.34B | |
| Retained Earnings | $32.64B | $32.30B | $32.07B | $31.61B | $31.48B | $31.32B | $30.92B | $30.55B | $30.40B | $30.66B | $30.26B | $30.27B | · | $30.12B | $29.80B | $30.28B | |
| AOCI | $-4.10B | $-4.33B | $-4.28B | $-4.60B | $-4.28B | $-2.84B | $-3.25B | $-3.41B | $-3.32B | $-3.46B | $-3.38B | $-3.67B | · | $-3.19B | $-2.36B | $-1.94B | |
| Stockholders' Equity | $49.46B | $48.98B | $48.65B | $47.89B | $48.02B | $49.39B | $48.49B | $47.95B | $50.21B | $51.79B | $51.46B | $51.18B | · | $51.44B | $51.88B | $52.67B | |
| Liabilities + Equity | $93.03B | $91.48B | $91.35B | $90.97B | $91.68B | $89.97B | $90.04B | $89.75B | $89.98B | $90.84B | $90.09B | $90.78B | · | $94.13B | $93.24B | $89.91B | |
| Shares Outstanding | 1,280,177,293 | 1,283,366,516 | 1,281,984,552 | 1,281,869,213 | 1,281,934,628 | 1,283,266,154 | 1,282,553,150 | 1,282,494,588 | 1,311,000,000 | 1,329,653,024 | 1,330,173,450 | 1,330,498,304 | 1,331,000,000 | 1,330,376,287 | 1,330,148,578 | 1,329,276,973 |
Cashflow 18
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $716M | $749M | $745M | $748M | $840M | $684M | $675M | $662M | $654M | $649M | $672M | $672M | $679M | $679M | $671M | $668M | |
| Stock-based Comp | $95M | $94M | $182M | $86M | $89M | $98M | $159M | $83M | $90M | $84M | $146M | $73M | $75M | $81M | $137M | $62M | |
| Amort. of Intangibles | $409M | $441M | $463M | $459M | $564M | $416M | $413M | $414M | $420M | $419M | $425M | $429M | $423M | $431M | $421M | $423M | |
| Restructuring | · | $172M | $13M | $67M | · | $46M | $46M | $62M | $300M | $55M | $91M | $91M | $300M | $104M | $95M | $76M | |
| Other Non-cash | · | · | · | $-786M | · | · | · | $-801M | · | · | · | $-661M | · | · | · | $-576M | |
| Operating Cash Flow | $2.57B | $2.74B | $925M | $1.09B | $2.53B | $2.57B | $958M | $986M | $2.78B | $2.47B | $661M | $875M | $2.46B | $1.57B | $922M | $1.08B | |
| CapEx | $488M | $444M | $468M | $504M | $459M | $476M | $404M | $520M | $426M | $346M | $461M | $354M | $378M | $332M | $323M | $426M | |
| Investing Cash Flow | $-917M | $-816M | $-482M | $-719M | $-490M | $-843M | $-345M | $-259M | $-696M | $-707M | $-424M | $-539M | $-475M | $-287M | $-1.15B | $-1.58B | |
| Debt Issued | $0 | $0 | $1.75B | $0 | $0 | $0 | $0 | $3.21B | $0 | $0 | $0 | $0 | $1.98B | $0 | · | · | |
| Net Debt Issued | · | · | · | $-1.16B | · | · | · | $3.21B | · | · | · | $0 | · | · | · | $-2.31B | |
| Stock Repurchased | $435M | $105M | $372M | $123M | $274M | $181M | $288M | $2.49B | $1.63B | $132M | $226M | $152M | $97M | $71M | $141M | $336M | |
| Net Stock Activity | · | · | · | $-123M | · | · | · | $-2.49B | · | · | · | $-152M | · | · | · | $-336M | |
| Dividends Paid | $908M | $911M | $910M | $910M | $897M | $897M | $897M | $898M | $913M | $917M | $918M | $918M | $905M | $904M | $904M | $903M | |
| Financing Cash Flow | $-888M | $-2.09B | $-395M | $-1.38B | $-1.34B | $-1.75B | $-534M | $-731M | $-2.36B | $-1.50B | $-90M | $-501M | $-4.89B | $-2.13B | $3.01B | $-950M | |
| Net Change in Cash | $803M | $-136M | $9M | $-945M | $978M | $-154M | $83M | $27M | $-339M | $312M | $-28M | $-204M | $-2.98B | $-306M | $2.69B | $-1.57B | |
| Taxes Paid | $344M | $204M | $992M | $402M | $304M | $180M | $941M | $394M | $219M | $293M | $993M | $117M | $234M | $493M | $561M | $260M | |
| Free Cash Flow | · | · | · | $584M | · | · | · | $466M | · | · | · | $521M | · | · | · | $657M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $422M | · | · | · | $511M |
Rentabilität 7
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 16.2% | 18.8% | 16.9% | · | 19.9% | 19.0% | 16.2% | · | 18.3% | 16.8% | 16.5% | · | 18.0% | 18.5% | 15.3% | |
| Net Margin | · | 12.7% | 15.3% | 12.1% | · | 15.6% | 15.1% | 13.2% | · | 16.3% | 11.4% | 10.3% | · | 15.8% | 5.6% | 12.6% | |
| Pretax Margin | · | 15.6% | 17.8% | 15.2% | · | 18.6% | 18.6% | 16.0% | · | 18.2% | 16.4% | 15.5% | · | 17.8% | 18.4% | 14.2% | |
| EBITDA Margin | · | 16.2% | 18.8% | 25.6% | · | 19.9% | 19.0% | 24.5% | · | 18.3% | 16.8% | 25.2% | · | 18.0% | 18.5% | 24.3% | |
| ROA | · | 1.3% | 1.5% | 1.1% | · | 1.4% | 1.4% | 1.1% | · | 1.4% | 0.99% | 0.88% | · | 1.3% | 0.46% | 1.0% | |
| ROE | · | 2.3% | 2.8% | 2.2% | · | 2.6% | 2.5% | 2.1% | · | 2.6% | 1.8% | 1.5% | · | 2.4% | 0.82% | 1.8% | |
| ROIC | · | 2.5% | 3.0% | 2.4% | · | 2.8% | 2.7% | 2.2% | · | 2.6% | 1.8% | 1.7% | · | 2.4% | 0.85% | 1.9% |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.5 | 2.4 | 2.0 | · | 1.9 | 1.8 | 2.1 | · | 2.3 | 2.3 | 2.4 | · | 1.8 | 1.8 | 1.6 | |
| Quick Ratio | · | 1.6 | 1.5 | 1.2 | · | 1.2 | 1.2 | 1.3 | · | 1.5 | 1.4 | 1.5 | · | 1.2 | 1.2 | 1.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.9 | 7.4 | 8.6 | · | 8.3 | 11.9 | 6.9 |
Effizienz 3
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | |
| Inventory Turnover | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | |
| Receivables Turnover | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.4 |
Bewertung (TTM) 10
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $34.85B | $34.23B | $33.19B | · | $32.70B | $32.39B | $31.69B | · | $31.50B | $31.00B | $30.39B | · | $30.45B | $30.57B | $30.97B | |
| Net Income TTM | · | $4.85B | $4.98B | $4.65B | · | $4.93B | $4.54B | $4.06B | · | $4.24B | $3.35B | $3.37B | · | $4.06B | $4.15B | $4.48B | |
| Market Cap | · | $129.47B | $120.08B | $119.14B | · | $115.74B | $116.19B | $100.93B | · | $115.07B | $92.35B | $117.42B | · | $109.86B | $115.48B | $122.98B | |
| P/E | · | 26.7 | 24.1 | 25.7 | · | 23.8 | 26.2 | 25.7 | · | 27.2 | 27.7 | 34.9 | · | 27.2 | 28.1 | 27.8 | |
| P/S | · | 3.7 | 3.5 | 3.6 | · | 3.5 | 3.6 | 3.2 | · | 3.7 | 3.0 | 3.9 | · | 3.6 | 3.8 | 4.0 | |
| P/B | · | 2.6 | 2.5 | 2.5 | · | 2.3 | 2.4 | 2.1 | · | 2.2 | 1.8 | 2.3 | · | 2.1 | 2.2 | 2.3 | |
| P / Cash Flow | · | · | · | 109.5 | · | · | · | 102.4 | · | · | · | 134.2 | · | · | · | 113.6 | |
| P / FCF | · | · | · | 204.0 | · | · | · | 216.6 | · | · | · | 225.4 | · | · | · | 187.2 | |
| Earnings Yield | · | 3.8% | 4.1% | 3.9% | · | 4.2% | 3.8% | 3.9% | · | 3.7% | 3.6% | 2.9% | · | 3.7% | 3.6% | 3.6% | |
| Payout Ratio | · | · | · | 87.5% | · | · | · | 86.2% | · | · | · | 116.1% | · | · | · | 97.2% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2026-04-24 | 2025-04-25 | 2024-04-26 | 2023-04-28 | 2022-04-29 | |
|---|---|---|---|---|---|
| Umsatz | $36.36B | $33.54B | $32.36B | $31.23B | $31.69B |
| Betriebsgewinnmarge % | 17.8% | 17.8% | 15.9% | 17.6% | 18.1% |
| Nettoergebnis | $4.80B | $4.66B | $3.68B | $3.76B | $5.04B |
| Verwässerte EPS | $3.73 | $3.61 | $2.76 | $2.82 | $3.73 |
Bilanz
| 2026-04-24 | 2025-04-25 | 2024-04-26 | 2023-04-28 | 2022-04-29 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | — | 0.0 | 0.0 | — | — |
| Liquiditätsgrad | 2.1 | 1.8 | 2.0 | 2.4 | 1.9 |
| Quick Ratio | 1.4 | 1.2 | 1.3 | 1.5 | 1.3 |
Cashflow
| 2026-04-24 | 2025-04-25 | 2024-04-26 | 2023-04-28 | 2022-04-29 | |
|---|---|---|---|---|---|
| Freier Cashflow | $5.43B | $5.18B | $5.20B | $4.58B | $5.98B |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
- US jury says Medtronic owes $88 million in first case to go to trial over Covidien's hernia mesh
- Got $2,500? 1 Unstoppable Medical Juggernaut to Buy Hand Over Fist and Hold for the Next 20 Years
- How To Earn $500 A Month From Medtronic Stock After Q4 Earnings
- Täglicher Dividendenbericht: MDT, ACM, UNH, RICK, VRT
- Warum Medtronic-Aktie heute sprang
- 3 Gesundheitsversicherungsaktien, die jeder Rentner berücksichtigen sollte
- Besser als Intuitive Surgical? 1 Under-the-Radar Healthcare Stock zum Kaufen und für immer Halten
- Medtronic plc (MDT) erhält die CE Mark für das Stealth AXiS™ chirurgische System
- Medtronic sagt, Cyberangriff auf IT-Netzwerk habe den Betrieb nicht gestört
- Medtronic plc (MDT): Innovationspipeline und strukturelle Veränderungen stützen den Bullenfall
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 2.346 Einreicher · $60.8B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 171 (-32 vs. Vorquartal) | 227 (+22 vs. Vorquartal) | 836 (-43 vs. Vorquartal) | 872 (-15 vs. Vorquartal) | +161.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $11.142.016.018 | 115.990.173 | 18,32% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.556.983.180 | 83.816.735 | 10,78% | Aktien |
| STATE STREET CORP | $5.005.319.950 | 63.399.315 | 8,23% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.664.511.218 | 34.059.967 | 4,38% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $2.023.116.235 | 25.984.601 | 3,33% | Aktien |
| NORGES BANK | $1.294.785.982 | 16.551.016 | 2,13% | Aktien |
| Capital Research Global Investors | $1.037.443.303 | 13.261.310 | 1,71% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1.008.596.703 | 12.892.710 | 1,66% | Aktien |
| WCM INVESTMENT MANAGEMENT, LLC | $876.149.302 | 10.826.014 | 1,44% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $796.817.845 | 10.185.579 | 1,31% | Aktien |
| Capital World Investors | $655.025.579 | 8.373.074 | 1,08% | Aktien |
| Dodge & Cox | $616.131.501 | 7.875.898 | 1,01% | Aktien |
| AMERIPRISE FINANCIAL INC | $615.938.087 | 7.872.026 | 1,01% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $573.774.724 | 6.621.751 | 0,94% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $563.897.017 | 7.208.194 | 0,93% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $494.651.395 | 6.323.038 | 0,81% | Aktien |
| Aristotle Capital Management, LLC | $492.360.887 | 6.293.698 | 0,81% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $482.957.188 | 6.173.570 | 0,79% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $481.385.824 | 6.153.467 | 0,79% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $466.253.773 | 5.960.038 | 0,77% | Aktien |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $452.879.494 | 5.789.077 | 0,74% | Aktien |
| BARCLAYS PLC | $426.360.776 | 5.450.093 | 0,70% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $420.775.311 | 5.378.561 | 0,69% | Aktien |
| GOLDMAN SACHS GROUP INC | $416.731.067 | 5.326.998 | 0,69% | Aktien |
| BlackRock, Inc. | $354.587.488 | 4.532.628 | 0,58% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $335.074.029 | 4.283.191 | 0,55% | Aktien |
| M&G PLC | $304.332.132 | 3.901.694 | 0,50% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $296.722.791 | 3.792.954 | 0,49% | Aktien |
| D. E. Shaw & Co., Inc. | $287.414.282 | 3.673.965 | 0,47% | Aktien |
| Swiss National Bank | $283.275.993 | 3.621.066 | 0,47% | Aktien |
| JANE STREET GROUP, LLC | $258.949.123 | 3.310.100 | 0,43% | Kaufoption |
| Sumitomo Mitsui Trust Group, Inc. | $257.469.246 | 3.291.183 | 0,42% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $253.531.461 | 3.240.847 | 0,42% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $251.158.901 | 3.210.519 | 0,41% | Aktien |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $250.336.000 | 3.200.000 | 0,41% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $247.812.378 | 3.167.741 | 0,41% | Aktien |
| National Pension Service | $247.426.235 | 3.162.805 | 0,41% | Aktien |
| Legal & General Group Plc | $240.655.505 | 3.076.256 | 0,40% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $226.173.178 | 2.891.131 | 0,37% | Aktien |
| Vanguard Global Advisers, LLC | $224.129.498 | 2.865.007 | 0,37% | Aktien |
| Qube Research & Technologies Ltd | $216.710.008 | 2.770.165 | 0,36% | Aktien |
| LPL Financial LLC | $205.056.905 | 2.621.206 | 0,34% | Aktien |
| Cullen Capital Management, LLC | $202.764.187 | 2.591.898 | 0,33% | Aktien |
| Burgundy Asset Management Ltd. | $202.732.865 | 2.184.386 | 0,33% | Aktien |
| Guinness Asset Management LTD | $201.485.632 | 2.584.951 | 0,33% | Aktien |
| USS Investment Management Ltd | $199.360.950 | 2.548.558 | 0,33% | Aktien |
| THORNBURG INVESTMENT MANAGEMENT INC | $196.492.638 | 2.511.730 | 0,32% | Aktien |
| UBS Group AG | $192.011.702 | 2.454.451 | 0,32% | Aktien |
| CITADEL ADVISORS LLC | $190.137.467 | 2.430.493 | 0,31% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $190.095.727 | 2.424.452 | 0,31% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $176.664.620 | 2.038.830 | 0,29% | Aktien |
| California Public Employees Retirement System | $175.498.444 | 2.243.365 | 0,29% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $173.135.446 | 2.138.003 | 0,28% | Aktien |
| RHUMBLINE ADVISERS | $173.126.323 | 2.213.044 | 0,28% | Aktien |
| ProShare Advisors LLC | $170.765.687 | 2.182.867 | 0,28% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $169.882.984 | 2.171.583 | 0,28% | Aktien |
| Squarepoint Ops LLC | $169.503.679 | 2.166.735 | 0,28% | Aktien |
| BANK OF NOVA SCOTIA | $164.717.802 | 2.105.558 | 0,27% | Aktien |
| EQUITY INVESTMENT CORP | $161.981.619 | 2.070.582 | 0,27% | Aktien |
| Brandywine Global Investment Management, LLC | $152.230.413 | 1.584.743 | 0,25% | Aktien |
| BANK OF AMERICA CORP /DE/ | $144.660.491 | 1.849.169 | 0,24% | Aktien |
| FMR LLC | $141.159.679 | 1.804.419 | 0,23% | Aktien |
| UBS Group AG | $139.937.824 | 1.788.800 | 0,23% | Verkaufsoption |
| CANADA PENSION PLAN INVESTMENT BOARD | $136.556.176 | 1.745.573 | 0,22% | Aktien |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $135.455.714 | 1.731.506 | 0,22% | Aktien |
| HSBC HOLDINGS PLC | $134.235.874 | 1.715.913 | 0,22% | Aktien |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $131.747.925 | 1.684.110 | 0,22% | Aktien |
| 1832 Asset Management L.P. | $131.702.630 | 1.683.531 | 0,22% | Aktien |
| FRANKLIN RESOURCES INC | $131.351.612 | 1.679.044 | 0,22% | Aktien |
| FEDERATED HERMES, INC. | $129.022.392 | 1.649.270 | 0,21% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $124.465.788 | 1.590.358 | 0,20% | Aktien |
| CITADEL ADVISORS LLC | $123.564.285 | 1.579.500 | 0,20% | Verkaufsoption |
| JANE STREET GROUP, LLC | $122.375.189 | 1.564.300 | 0,20% | Verkaufsoption |
| PANAGORA ASSET MANAGEMENT INC | $121.070.782 | 1.547.626 | 0,20% | Aktien |
| CRAWFORD INVESTMENT COUNSEL INC | $119.126.812 | 1.522.777 | 0,20% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $112.773.502 | 1.301.483 | 0,19% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $110.448.713 | 1.411.846 | 0,18% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $100.190.256 | 1.280.714 | 0,16% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $99.640.612 | 1.273.688 | 0,16% | Aktien |
| Bank of New York Mellon Corp | $97.828.023 | 1.250.518 | 0,16% | Aktien |
| MACKENZIE FINANCIAL CORP | $94.730.976 | 1.210.929 | 0,16% | Aktien |
| Saratoga Research & Investment Management | $94.132.986 | 1.203.285 | 0,15% | Aktien |
| Aberdeen Group plc | $90.825.030 | 1.161.000 | 0,15% | Aktien |
| Pictet Asset Management Holding SA | $89.793.686 | 1.147.659 | 0,15% | Aktien |
| CIBC Asset Management Inc | $89.727.698 | 1.146.973 | 0,15% | Aktien |
| Trexquant Investment LP | $88.614.328 | 1.132.741 | 0,15% | Aktien |
| DAVENPORT & Co LLC | $86.729.900 | 1.098.548 | 0,14% | Aktien |
| CAPITAL FUND MANAGEMENT S.A. | $86.011.381 | 1.099.468 | 0,14% | Aktien |
| AVIVA PLC | $85.897.322 | 1.098.010 | 0,14% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $85.550.607 | 1.093.578 | 0,14% | Aktien |
| FLOSSBACH VON STORCH SE | $85.222.667 | 1.089.386 | 0,14% | Aktien |
| STOREBRAND ASSET MANAGEMENT AS | $83.546.980 | 1.067.966 | 0,14% | Aktien |
| Korea Investment CORP | $83.300.869 | 1.064.820 | 0,14% | Aktien |
| Baird Financial Group, Inc. | $82.750.131 | 1.057.780 | 0,14% | Aktien |
| Bank Julius Baer & Co. Ltd, Zurich | $80.700.169 | 1.024.935 | 0,13% | Aktien |
| NOMURA HOLDINGS INC | $78.230.000 | 1.000.000 | 0,13% | Verkaufsoption |
| Bellevue Group AG | $77.778.848 | 994.233 | 0,13% | Aktien |
| Balyasny Asset Management L.P. | $77.109.121 | 985.672 | 0,13% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $74.893.021 | 957.344 | 0,12% | Aktien |
| TD Asset Management Inc | $73.048.749 | 933.769 | 0,12% | Aktien |
Unternehmensinsider 42 Insider · 25 Führungskräfte · 15 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Geoffrey Martha | Chairman and CEO | 3. August 2026 A | 327.866 | 0 | 0 | $0 |
| Thierry Pieton | EVP & Chief Financial Officer | 3. August 2026 A | 49.645 | 0 | 0 | $0 |
| Karen L Parkhill | EVP & Chief Financial Officer | 1. August 2022 A | 30.962 | 0 | 0 | $0 |
| Kweli Thompson | EVP & President, Neuroscience | 3. August 2026 A | 35.390 | 0 | 0 | $0 |
| Denise L. Blomquist | Chief Accounting Officer | 3. August 2026 A | 16.998 | 0 | 0 | $0 |
| Matthew R. Walter | SVP, Chief HR Officer | 3. August 2026 A | 39.928 | 0 | 1 | $-257.931 |
| Michael Marinaro | EVP, Pres MedSurg and Americas | 3. August 2026 A | 117.420 | 0 | 0 | $0 |
| Michelle Quinn | EVP, GC and Secretary | 3. August 2026 A | 26.721 | 0 | 0 | $0 |
| Harry Skip Kiil | EVP & President Cardiovascular | 3. August 2026 A | 43.669 | 0 | 1 | $-318.623 |
| Gregory L Smith | EVP Global Ops & Supply Chain | 18. April 2023 F | 28.882 | 0 | 0 | $0 |
| Jennifer M Kirk | Chief Accounting Officer | 1. Februar 2023 F | 10.115 | 0 | 0 | $0 |
| Sean Salmon | EVP & President Cardiovascular | 13. Dezember 2022 M | 36.088 | 0 | 0 | $0 |
| Ivan K Fong | EVP GENERAL COUNSEL & SECR | 9. Dezember 2022 F | 32.830 | 0 | 0 | $0 |
| Robert John White | EVP & Pres. Medical Surgical | 7. Dezember 2022 F | 36.186 | 0 | 0 | $0 |
| Brett A. Wall | EVP & Pres Neuroscience | 7. Dezember 2022 F | 25.470 | 0 | 0 | $0 |
| Rob Ten Hoedt | EVP and Pres. Global Regions | 14. Oktober 2022 M | 43.483 | 0 | 0 | $0 |
| Carol A Surface | EVP, Chief HR Officer | 1. August 2022 A | 26.193 | 0 | 0 | $0 |
| John R Liddicoat | EVP & President of Americas | 29. Juli 2022 D | 37.374 | 0 | 0 | $0 |
| Bradley E Lerman | SVP General Counsel & Corp Sec | 5. November 2021 F | 48.635 | 0 | 0 | $0 |
| Richard Kuntz | SVP & Chief Medical & Science | 5. November 2021 F | 74.945 | 0 | 0 | $0 |
| Michael J Coyle | EVP & Group Pres, Cardiac&Vasc | 3. November 2020 F | 190.390 | 0 | 0 | $0 |
| Omar Ishrak | Executive Chairman | 15. Oktober 2020 G | 8.650 | 0 | 0 | $0 |
| Hooman Hakami | EVP & Group President Diabetes | 10. September 2019 M | 30.761 | 0 | 0 | $0 |
| Bryan C Hanson | EVP, President, MITG | 15. Dezember 2017 S | 88.818 | 0 | 0 | $0 |
| Gary Lee Ellis | EVP & Global Ops and IT | 30. Dezember 2016 G | 180.718 | 0 | 0 | $0 |
| Randall J Hogan | Direktor | 28. April 2026 F | 48.998 | 0 | 0 | $0 |
| Craig Arnold | Direktor | 28. April 2026 F | 42.185 | 0 | 0 | $0 |
| William R Jellison | Direktor | 27. April 2026 A | 6.444 | 0 | 0 | $0 |
| Andrea Jo Goldsmith | Direktor | 3. Mai 2022 F | 4.450 | 0 | 0 | $0 |
| Elizabeth G Nabel | Direktor | 3. Mai 2022 F | 11.818 | 0 | 0 | $0 |
| Kevin E Lofton | Direktor | 3. Mai 2022 F | 2.374 | 0 | 0 | $0 |
| Richard H Anderson | Direktor | 3. Mai 2022 F | 110.182 | 0 | 0 | $0 |
| Denise M Oleary | Direktor | 3. Mai 2022 F | 70.917 | 0 | 0 | $0 |
| Michael O Leavitt | Direktor | 3. Mai 2021 A | 21.779 | 0 | 0 | $0 |
| James T Lenehan | Direktor | 3. Mai 2021 A | 57.849 | 0 | 0 | $0 |
| Robert C Pozen | Direktor | 23. August 2018 M | 60.964 | 0 | 0 | $0 |
| Shirley A Jackson | Direktor | 1. Mai 2018 F | 38.525 | 0 | 0 | $0 |
| Preetha Reddy | Direktor | 2. Mai 2016 A | 7.823 | 0 | 0 | $0 |
| Medtronic plc | 10%-Eigentümer | 30. Januar 2023 P | 4.999.423 | 0 | 0 | $0 |
| Kendall J Powell | — | 28. April 2026 F | 51.380 | 0 | 0 | $0 |
| Scott C Donnelly | — | 28. April 2026 F | 23.679 | 0 | 0 | $0 |
| Christopher J Oconnell | — | 19. Februar 2015 M | 93.274 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Medtronic plc (2), Covidien Group S.a.r.l. (2) | 21. September 2018 | — | Erste Einreichung | — | SEC |
| Medtronic plc, Medtronic, Inc., Medtronic International, Ltd. | 16. Februar 2016 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 127 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHI · iShares Trust | 4,42% | 1.722.654 SH | 8. August 2026 | Täglich |
| CAMX · ADVISORS' INNER CIRCLE FUND | 3,23% | 26.363 NS | 30. April 2026 | N-PORT |
| AGNG · Global X Funds | 2,60% | 28.814 NS | 31. Mai 2026 | N-PORT |
| FLV · AMERICAN CENTURY ETF TRUST | 2,46% | 117.685 NS | 31. Mai 2026 | N-PORT |
| ELCV · Strategy Shares | 2,45% | 66.771 NS | 30. April 2026 | N-PORT |
| ESLV · Strategy Shares | 2,05% | 2.980 NS | 30. April 2026 | N-PORT |
| IYH · iShares Trust | 1,79% | 768.039 SH | 8. August 2026 | Täglich |
| HDV · iShares Trust | 1,74% | 2.992.369 SH | 8. August 2026 | Täglich |
| SPHD · Invesco Exchange-Traded Fund Trust … | 1,72% | 676.993 SH | 8. August 2026 | Täglich |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,64% | 147.709 SH | 8. August 2026 | Täglich |
| GEND · Spinnaker ETF Series | 1,60% | 883 NS | 30. April 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1,50% | 25.563 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 1,48% | 3.859.616 SH | 8. August 2026 | Täglich |
| IXJ · iShares Trust | 1,39% | 674.832 SH | 8. August 2026 | Täglich |
| QDIV · Global X Funds | 1,31% | 5.813 NS | 31. Mai 2026 | N-PORT |
| SIXH · EXCHANGE TRADED CONCEPTS TRUST | 1,19% | 87.694 NS | 31. Mai 2026 | N-PORT |
| SIXA · EXCHANGE TRADED CONCEPTS TRUST | 1,19% | 78.578 NS | 31. Mai 2026 | N-PORT |
| SPLV · Invesco Exchange-Traded Fund Trust … | 1,05% | 860.517 SH | 8. August 2026 | Täglich |
| CVAR · ETF Opportunities Trust | 1,04% | 4.958 NS | 30. April 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 1,02% | 326.368 SH | 8. August 2026 | Täglich |
| ESUM · Strategy Shares | 0,98% | 18.719 NS | 30. April 2026 | N-PORT |
| PICB · Invesco Exchange-Traded Fund Trust … | 0,84% | 3.100.000 | 8. August 2026 | Täglich |
| DGRO · iShares Trust | 0,82% | 4.167.912 SH | 8. August 2026 | Täglich |
| LQAI · Exchange Listed Funds Trust | 0,71% | 186 NS | 30. April 2026 | N-PORT |
| DIVB · iShares Trust | 0,69% | 141.416 SH | 8. August 2026 | Täglich |
| VALQ · AMERICAN CENTURY ETF TRUST | 0,68% | 31.914 NS | 31. Mai 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,53% | 57.783 SH | 8. August 2026 | Täglich |
| AUSF · Global X Funds | 0,51% | 58.256 NS | 31. Mai 2026 | N-PORT |
| CATH · Global X Funds | 0,48% | 72.153 NS | 30. April 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0,47% | 806.965 SH | 8. August 2026 | Täglich |
| DFUV · Dimensional ETF Trust | 0,45% | 803.592 NS | 30. April 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0,45% | 324.471 NS | 30. April 2026 | N-PORT |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,44% | 7.253.284 SH | 8. August 2026 | Täglich |
| VYM · VANGUARD WHITEHALL FUNDS | 0,42% | 5.120.062 SH | 8. August 2026 | Täglich |
| VFMV · VANGUARD WELLINGTON FUND | 0,41% | 21.916 SH | 8. August 2026 | Täglich |
| IWX · iShares Trust | 0,41% | 189.708 SH | 8. August 2026 | Täglich |
| PFM · Invesco Exchange-Traded Fund Trust | 0,39% | 36.544 SH | 8. August 2026 | Täglich |
| ESLG · Strategy Shares | 0,39% | 931 NS | 30. April 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,38% | 12.209.067 SH | 8. August 2026 | Täglich |
| IVE · iShares Trust | 0,37% | 2.126.837 SH | 8. August 2026 | Täglich |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,36% | 39.236 SH | 8. August 2026 | Täglich |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,35% | 295.656 SH | 8. August 2026 | Täglich |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,35% | 430.000 | 8. August 2026 | Täglich |
| IUSV · iShares Trust | 0,35% | 1.116.339 SH | 8. August 2026 | Täglich |
| ILCV · iShares Trust | 0,32% | 50.022 SH | 8. August 2026 | Täglich |
| CHRI · Global X Funds | 0,31% | 196 NS | 30. April 2026 | N-PORT |
| IWD · iShares Trust | 0,29% | 2.847.266 SH | 8. August 2026 | Täglich |
| DYNF · BlackRock ETF Trust | 0,29% | 1.333.378 SH | 8. August 2026 | Täglich |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,28% | 774.434 SH | 8. August 2026 | Täglich |
| EGLE · Global X Funds | 0,26% | 65 NS | 30. April 2026 | N-PORT |